Atlas Trials

A Trial to Assess the Efficacy and Safety of Morinidazole in Women With Pelvic Inflammatory Disease

Clinical trial NCT03391440 · UNKNOWN

Trial details

NCT number
NCT03391440
Sponsor
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Pelvic Inflammatory Disease
Start date
2016-09-01
Primary completion
2018-12-01
Enrollment
469

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.